カテゴリー： Market Monitor Global, 世界, 医療/バイオ

局所投与用抗真菌薬の世界市場見通し2023年-2029年

◆英語タイトル：Topical Antifungals Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8127 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：119 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Topical Antifungals Market 調査レポートは次の情報を含め、グローバルにおけるの局所投与用抗真菌薬市場規模と予測を収録しています。・世界の局所投与用抗真菌薬市場：売上、2018年-2023年、2024年-2029年
・世界の局所投与用抗真菌薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の局所投与用抗真菌薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「粉末」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

局所投与用抗真菌薬のグローバル主要企業は、Bayer、 Coloplast、 Sandoz、 3M、 Schering-Plough、 Zydus Lifesciences、 Teva Pharmaceuticals、 Perrigo Pharmaceuticals、 Roxane Laboratories、 AdvaCare Pharma、 Smith & Nephew Wound Care、 Taro Pharmaceutical、 Teligent、 G & W Labs、 Glenmark Pharmaceuticals、 Mayne Pharma、 TruPharma、 Viona Pharmaceuticals、 Zydus Pharmaceuticals、 Acella Pharmaceuticals、 Akorn、 Alembic Pharmaceuticals、 Bausch & Lomb Americas、 Encubeなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、局所投与用抗真菌薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の局所投与用抗真菌薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の局所投与用抗真菌薬市場：タイプ別市場シェア、2022年
・粉末、クリーム、軟膏、その他

世界の局所投与用抗真菌薬市場：用途別、2018年-2023年、2024年-2029年
世界の局所投与用抗真菌薬市場：用途別市場シェア、2022年
・病院、診療所、薬局、家庭用、その他

世界の局所投与用抗真菌薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の局所投与用抗真菌薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における局所投与用抗真菌薬のグローバル売上、2018年-2023年
・主要企業における局所投与用抗真菌薬のグローバル売上シェア、2022年
・主要企業における局所投与用抗真菌薬のグローバル販売量、2018年-2023年
・主要企業における局所投与用抗真菌薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer、 Coloplast、 Sandoz、 3M、 Schering-Plough、 Zydus Lifesciences、 Teva Pharmaceuticals、 Perrigo Pharmaceuticals、 Roxane Laboratories、 AdvaCare Pharma、 Smith & Nephew Wound Care、 Taro Pharmaceutical、 Teligent、 G & W Labs、 Glenmark Pharmaceuticals、 Mayne Pharma、 TruPharma、 Viona Pharmaceuticals、 Zydus Pharmaceuticals、 Acella Pharmaceuticals、 Akorn、 Alembic Pharmaceuticals、 Bausch & Lomb Americas、 Encube

*************************************************************

・調査・分析レポートの概要
局所投与用抗真菌薬市場の定義
市場セグメント
世界の局所投与用抗真菌薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の局所投与用抗真菌薬市場規模
世界の局所投与用抗真菌薬市場規模：2022年 VS 2029年
世界の局所投与用抗真菌薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの局所投与用抗真菌薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の局所投与用抗真菌薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：粉末、クリーム、軟膏、その他
局所投与用抗真菌薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、薬局、家庭用、その他
局所投与用抗真菌薬の用途別グローバル売上・予測

・地域別市場分析
地域別局所投与用抗真菌薬市場規模 2022年と2029年
地域別局所投与用抗真菌薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Coloplast、 Sandoz、 3M、 Schering-Plough、 Zydus Lifesciences、 Teva Pharmaceuticals、 Perrigo Pharmaceuticals、 Roxane Laboratories、 AdvaCare Pharma、 Smith & Nephew Wound Care、 Taro Pharmaceutical、 Teligent、 G & W Labs、 Glenmark Pharmaceuticals、 Mayne Pharma、 TruPharma、 Viona Pharmaceuticals、 Zydus Pharmaceuticals、 Acella Pharmaceuticals、 Akorn、 Alembic Pharmaceuticals、 Bausch & Lomb Americas、 Encube
...

This report aims to provide a comprehensive presentation of the global market for Topical Antifungals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Antifungals. This report contains market size and forecasts of Topical Antifungals in global, including the following market information:
Global Topical Antifungals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Topical Antifungals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Powder Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Topical Antifungals include Bayer, Coloplast, Sandoz, 3M, Schering-Plough, Zydus Lifesciences, Teva Pharmaceuticals, Perrigo Pharmaceuticals and Roxane Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Topical Antifungals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Topical Antifungals Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Topical Antifungals Market Segment Percentages, by Type, 2022 (%)
Powder
Cream
Ointment
Others
Global Topical Antifungals Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Topical Antifungals Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Pharmacy
Home
Others
Global Topical Antifungals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Topical Antifungals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Topical Antifungals revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Topical Antifungals revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Coloplast
Sandoz
3M
Schering-Plough
Zydus Lifesciences
Teva Pharmaceuticals
Perrigo Pharmaceuticals
Roxane Laboratories
AdvaCare Pharma
Smith & Nephew Wound Care
Taro Pharmaceutical
Teligent
G & W Labs
Glenmark Pharmaceuticals
Mayne Pharma
TruPharma
Viona Pharmaceuticals
Zydus Pharmaceuticals
Acella Pharmaceuticals
Akorn
Alembic Pharmaceuticals
Bausch & Lomb Americas
Encube
Outline of Major Chapters:
Chapter 1: Introduces the definition of Topical Antifungals, market overview.
Chapter 2: Global Topical Antifungals market size in revenue.
Chapter 3: Detailed analysis of Topical Antifungals company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Topical Antifungals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Topical Antifungals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Topical Antifungals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Topical Antifungals Overall Market Size
2.1 Global Topical Antifungals Market Size: 2022 VS 2029
2.2 Global Topical Antifungals Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Topical Antifungals Players in Global Market
3.2 Top Global Topical Antifungals Companies Ranked by Revenue
3.3 Global Topical Antifungals Revenue by Companies
3.4 Top 3 and Top 5 Topical Antifungals Companies in Global Market, by Revenue in 2022
3.5 Global Companies Topical Antifungals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Topical Antifungals Players in Global Market
3.6.1 List of Global Tier 1 Topical Antifungals Companies
3.6.2 List of Global Tier 2 and Tier 3 Topical Antifungals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Topical Antifungals Market Size Markets, 2022 & 2029
4.1.2 Powder
4.1.3 Cream
4.1.4 Ointment
4.1.5 Others
4.2 By Type – Global Topical Antifungals Revenue & Forecasts
4.2.1 By Type – Global Topical Antifungals Revenue, 2018-2023
4.2.2 By Type – Global Topical Antifungals Revenue, 2024-2029
4.2.3 By Type – Global Topical Antifungals Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Topical Antifungals Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Pharmacy
5.1.5 Home
5.1.6 Others
5.2 By Application – Global Topical Antifungals Revenue & Forecasts
5.2.1 By Application – Global Topical Antifungals Revenue, 2018-2023
5.2.2 By Application – Global Topical Antifungals Revenue, 2024-2029
5.2.3 By Application – Global Topical Antifungals Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Topical Antifungals Market Size, 2022 & 2029
6.2 By Region – Global Topical Antifungals Revenue & Forecasts
6.2.1 By Region – Global Topical Antifungals Revenue, 2018-2023
6.2.2 By Region – Global Topical Antifungals Revenue, 2024-2029
6.2.3 By Region – Global Topical Antifungals Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Topical Antifungals Revenue, 2018-2029
6.3.2 US Topical Antifungals Market Size, 2018-2029
6.3.3 Canada Topical Antifungals Market Size, 2018-2029
6.3.4 Mexico Topical Antifungals Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Topical Antifungals Revenue, 2018-2029
6.4.2 Germany Topical Antifungals Market Size, 2018-2029
6.4.3 France Topical Antifungals Market Size, 2018-2029
6.4.4 U.K. Topical Antifungals Market Size, 2018-2029
6.4.5 Italy Topical Antifungals Market Size, 2018-2029
6.4.6 Russia Topical Antifungals Market Size, 2018-2029
6.4.7 Nordic Countries Topical Antifungals Market Size, 2018-2029
6.4.8 Benelux Topical Antifungals Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Topical Antifungals Revenue, 2018-2029
6.5.2 China Topical Antifungals Market Size, 2018-2029
6.5.3 Japan Topical Antifungals Market Size, 2018-2029
6.5.4 South Korea Topical Antifungals Market Size, 2018-2029
6.5.5 Southeast Asia Topical Antifungals Market Size, 2018-2029
6.5.6 India Topical Antifungals Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Topical Antifungals Revenue, 2018-2029
6.6.2 Brazil Topical Antifungals Market Size, 2018-2029
6.6.3 Argentina Topical Antifungals Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Topical Antifungals Revenue, 2018-2029
6.7.2 Turkey Topical Antifungals Market Size, 2018-2029
6.7.3 Israel Topical Antifungals Market Size, 2018-2029
6.7.4 Saudi Arabia Topical Antifungals Market Size, 2018-2029
6.7.5 UAE Topical Antifungals Market Size, 2018-2029
7 Topical Antifungals Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Topical Antifungals Major Product Offerings
7.1.4 Bayer Topical Antifungals Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Coloplast
7.2.1 Coloplast Company Summary
7.2.2 Coloplast Business Overview
7.2.3 Coloplast Topical Antifungals Major Product Offerings
7.2.4 Coloplast Topical Antifungals Revenue in Global Market (2018-2023)
7.2.5 Coloplast Key News & Latest Developments
7.3 Sandoz
7.3.1 Sandoz Company Summary
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Topical Antifungals Major Product Offerings
7.3.4 Sandoz Topical Antifungals Revenue in Global Market (2018-2023)
7.3.5 Sandoz Key News & Latest Developments
7.4 3M
7.4.1 3M Company Summary
7.4.2 3M Business Overview
7.4.3 3M Topical Antifungals Major Product Offerings
7.4.4 3M Topical Antifungals Revenue in Global Market (2018-2023)
7.4.5 3M Key News & Latest Developments
7.5 Schering-Plough
7.5.1 Schering-Plough Company Summary
7.5.2 Schering-Plough Business Overview
7.5.3 Schering-Plough Topical Antifungals Major Product Offerings
7.5.4 Schering-Plough Topical Antifungals Revenue in Global Market (2018-2023)
7.5.5 Schering-Plough Key News & Latest Developments
7.6 Zydus Lifesciences
7.6.1 Zydus Lifesciences Company Summary
7.6.2 Zydus Lifesciences Business Overview
7.6.3 Zydus Lifesciences Topical Antifungals Major Product Offerings
7.6.4 Zydus Lifesciences Topical Antifungals Revenue in Global Market (2018-2023)
7.6.5 Zydus Lifesciences Key News & Latest Developments
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Company Summary
7.7.2 Teva Pharmaceuticals Business Overview
7.7.3 Teva Pharmaceuticals Topical Antifungals Major Product Offerings
7.7.4 Teva Pharmaceuticals Topical Antifungals Revenue in Global Market (2018-2023)
7.7.5 Teva Pharmaceuticals Key News & Latest Developments
7.8 Perrigo Pharmaceuticals
7.8.1 Perrigo Pharmaceuticals Company Summary
7.8.2 Perrigo Pharmaceuticals Business Overview
7.8.3 Perrigo Pharmaceuticals Topical Antifungals Major Product Offerings
7.8.4 Perrigo Pharmaceuticals Topical Antifungals Revenue in Global Market (2018-2023)
7.8.5 Perrigo Pharmaceuticals Key News & Latest Developments
7.9 Roxane Laboratories
7.9.1 Roxane Laboratories Company Summary
7.9.2 Roxane Laboratories Business Overview
7.9.3 Roxane Laboratories Topical Antifungals Major Product Offerings
7.9.4 Roxane Laboratories Topical Antifungals Revenue in Global Market (2018-2023)
7.9.5 Roxane Laboratories Key News & Latest Developments
7.10 AdvaCare Pharma
7.10.1 AdvaCare Pharma Company Summary
7.10.2 AdvaCare Pharma Business Overview
7.10.3 AdvaCare Pharma Topical Antifungals Major Product Offerings
7.10.4 AdvaCare Pharma Topical Antifungals Revenue in Global Market (2018-2023)
7.10.5 AdvaCare Pharma Key News & Latest Developments
7.11 Smith & Nephew Wound Care
7.11.1 Smith & Nephew Wound Care Company Summary
7.11.2 Smith & Nephew Wound Care Business Overview
7.11.3 Smith & Nephew Wound Care Topical Antifungals Major Product Offerings
7.11.4 Smith & Nephew Wound Care Topical Antifungals Revenue in Global Market (2018-2023)
7.11.5 Smith & Nephew Wound Care Key News & Latest Developments
7.12 Taro Pharmaceutical
7.12.1 Taro Pharmaceutical Company Summary
7.12.2 Taro Pharmaceutical Business Overview
7.12.3 Taro Pharmaceutical Topical Antifungals Major Product Offerings
7.12.4 Taro Pharmaceutical Topical Antifungals Revenue in Global Market (2018-2023)
7.12.5 Taro Pharmaceutical Key News & Latest Developments
7.13 Teligent
7.13.1 Teligent Company Summary
7.13.2 Teligent Business Overview
7.13.3 Teligent Topical Antifungals Major Product Offerings
7.13.4 Teligent Topical Antifungals Revenue in Global Market (2018-2023)
7.13.5 Teligent Key News & Latest Developments
7.14 G & W Labs
7.14.1 G & W Labs Company Summary
7.14.2 G & W Labs Business Overview
7.14.3 G & W Labs Topical Antifungals Major Product Offerings
7.14.4 G & W Labs Topical Antifungals Revenue in Global Market (2018-2023)
7.14.5 G & W Labs Key News & Latest Developments
7.15 Glenmark Pharmaceuticals
7.15.1 Glenmark Pharmaceuticals Company Summary
7.15.2 Glenmark Pharmaceuticals Business Overview
7.15.3 Glenmark Pharmaceuticals Topical Antifungals Major Product Offerings
7.15.4 Glenmark Pharmaceuticals Topical Antifungals Revenue in Global Market (2018-2023)
7.15.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.16 Mayne Pharma
7.16.1 Mayne Pharma Company Summary
7.16.2 Mayne Pharma Business Overview
7.16.3 Mayne Pharma Topical Antifungals Major Product Offerings
7.16.4 Mayne Pharma Topical Antifungals Revenue in Global Market (2018-2023)
7.16.5 Mayne Pharma Key News & Latest Developments
7.17 TruPharma
7.17.1 TruPharma Company Summary
7.17.2 TruPharma Business Overview
7.17.3 TruPharma Topical Antifungals Major Product Offerings
7.17.4 TruPharma Topical Antifungals Revenue in Global Market (2018-2023)
7.17.5 TruPharma Key News & Latest Developments
7.18 Viona Pharmaceuticals
7.18.1 Viona Pharmaceuticals Company Summary
7.18.2 Viona Pharmaceuticals Business Overview
7.18.3 Viona Pharmaceuticals Topical Antifungals Major Product Offerings
7.18.4 Viona Pharmaceuticals Topical Antifungals Revenue in Global Market (2018-2023)
7.18.5 Viona Pharmaceuticals Key News & Latest Developments
7.19 Zydus Pharmaceuticals
7.19.1 Zydus Pharmaceuticals Company Summary
7.19.2 Zydus Pharmaceuticals Business Overview
7.19.3 Zydus Pharmaceuticals Topical Antifungals Major Product Offerings
7.19.4 Zydus Pharmaceuticals Topical Antifungals Revenue in Global Market (2018-2023)
7.19.5 Zydus Pharmaceuticals Key News & Latest Developments
7.20 Acella Pharmaceuticals
7.20.1 Acella Pharmaceuticals Company Summary
7.20.2 Acella Pharmaceuticals Business Overview
7.20.3 Acella Pharmaceuticals Topical Antifungals Major Product Offerings
7.20.4 Acella Pharmaceuticals Topical Antifungals Revenue in Global Market (2018-2023)
7.20.5 Acella Pharmaceuticals Key News & Latest Developments
7.21 Akorn
7.21.1 Akorn Company Summary
7.21.2 Akorn Business Overview
7.21.3 Akorn Topical Antifungals Major Product Offerings
7.21.4 Akorn Topical Antifungals Revenue in Global Market (2018-2023)
7.21.5 Akorn Key News & Latest Developments
7.22 Alembic Pharmaceuticals
7.22.1 Alembic Pharmaceuticals Company Summary
7.22.2 Alembic Pharmaceuticals Business Overview
7.22.3 Alembic Pharmaceuticals Topical Antifungals Major Product Offerings
7.22.4 Alembic Pharmaceuticals Topical Antifungals Revenue in Global Market (2018-2023)
7.22.5 Alembic Pharmaceuticals Key News & Latest Developments
7.23 Bausch & Lomb Americas
7.23.1 Bausch & Lomb Americas Company Summary
7.23.2 Bausch & Lomb Americas Business Overview
7.23.3 Bausch & Lomb Americas Topical Antifungals Major Product Offerings
7.23.4 Bausch & Lomb Americas Topical Antifungals Revenue in Global Market (2018-2023)
7.23.5 Bausch & Lomb Americas Key News & Latest Developments
7.24 Encube
7.24.1 Encube Company Summary
7.24.2 Encube Business Overview
7.24.3 Encube Topical Antifungals Major Product Offerings
7.24.4 Encube Topical Antifungals Revenue in Global Market (2018-2023)
7.24.5 Encube Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Topical Antifungals Market Opportunities & Trends in Global Market
Table 2. Topical Antifungals Market Drivers in Global Market
Table 3. Topical Antifungals Market Restraints in Global Market
Table 4. Key Players of Topical Antifungals in Global Market
Table 5. Top Topical Antifungals Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Topical Antifungals Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Topical Antifungals Revenue Share by Companies, 2018-2023
Table 8. Global Companies Topical Antifungals Product Type
Table 9. List of Global Tier 1 Topical Antifungals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Topical Antifungals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Topical Antifungals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Topical Antifungals Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Topical Antifungals Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Topical Antifungals Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Topical Antifungals Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Topical Antifungals Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Topical Antifungals Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Topical Antifungals Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Topical Antifungals Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Topical Antifungals Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Topical Antifungals Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Topical Antifungals Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Topical Antifungals Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Topical Antifungals Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Topical Antifungals Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Topical Antifungals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Topical Antifungals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Topical Antifungals Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Topical Antifungals Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Topical Antifungals Product Offerings
Table 32. Bayer Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Coloplast Company Summary
Table 35. Coloplast Topical Antifungals Product Offerings
Table 36. Coloplast Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 37. Coloplast Key News & Latest Developments
Table 38. Sandoz Company Summary
Table 39. Sandoz Topical Antifungals Product Offerings
Table 40. Sandoz Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 41. Sandoz Key News & Latest Developments
Table 42. 3M Company Summary
Table 43. 3M Topical Antifungals Product Offerings
Table 44. 3M Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 45. 3M Key News & Latest Developments
Table 46. Schering-Plough Company Summary
Table 47. Schering-Plough Topical Antifungals Product Offerings
Table 48. Schering-Plough Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 49. Schering-Plough Key News & Latest Developments
Table 50. Zydus Lifesciences Company Summary
Table 51. Zydus Lifesciences Topical Antifungals Product Offerings
Table 52. Zydus Lifesciences Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 53. Zydus Lifesciences Key News & Latest Developments
Table 54. Teva Pharmaceuticals Company Summary
Table 55. Teva Pharmaceuticals Topical Antifungals Product Offerings
Table 56. Teva Pharmaceuticals Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Pharmaceuticals Key News & Latest Developments
Table 58. Perrigo Pharmaceuticals Company Summary
Table 59. Perrigo Pharmaceuticals Topical Antifungals Product Offerings
Table 60. Perrigo Pharmaceuticals Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 61. Perrigo Pharmaceuticals Key News & Latest Developments
Table 62. Roxane Laboratories Company Summary
Table 63. Roxane Laboratories Topical Antifungals Product Offerings
Table 64. Roxane Laboratories Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 65. Roxane Laboratories Key News & Latest Developments
Table 66. AdvaCare Pharma Company Summary
Table 67. AdvaCare Pharma Topical Antifungals Product Offerings
Table 68. AdvaCare Pharma Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 69. AdvaCare Pharma Key News & Latest Developments
Table 70. Smith & Nephew Wound Care Company Summary
Table 71. Smith & Nephew Wound Care Topical Antifungals Product Offerings
Table 72. Smith & Nephew Wound Care Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 73. Smith & Nephew Wound Care Key News & Latest Developments
Table 74. Taro Pharmaceutical Company Summary
Table 75. Taro Pharmaceutical Topical Antifungals Product Offerings
Table 76. Taro Pharmaceutical Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 77. Taro Pharmaceutical Key News & Latest Developments
Table 78. Teligent Company Summary
Table 79. Teligent Topical Antifungals Product Offerings
Table 80. Teligent Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 81. Teligent Key News & Latest Developments
Table 82. G & W Labs Company Summary
Table 83. G & W Labs Topical Antifungals Product Offerings
Table 84. G & W Labs Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 85. G & W Labs Key News & Latest Developments
Table 86. Glenmark Pharmaceuticals Company Summary
Table 87. Glenmark Pharmaceuticals Topical Antifungals Product Offerings
Table 88. Glenmark Pharmaceuticals Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 89. Glenmark Pharmaceuticals Key News & Latest Developments
Table 90. Mayne Pharma Company Summary
Table 91. Mayne Pharma Topical Antifungals Product Offerings
Table 92. Mayne Pharma Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 93. Mayne Pharma Key News & Latest Developments
Table 94. TruPharma Company Summary
Table 95. TruPharma Topical Antifungals Product Offerings
Table 96. TruPharma Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 97. TruPharma Key News & Latest Developments
Table 98. Viona Pharmaceuticals Company Summary
Table 99. Viona Pharmaceuticals Topical Antifungals Product Offerings
Table 100. Viona Pharmaceuticals Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 101. Viona Pharmaceuticals Key News & Latest Developments
Table 102. Zydus Pharmaceuticals Company Summary
Table 103. Zydus Pharmaceuticals Topical Antifungals Product Offerings
Table 104. Zydus Pharmaceuticals Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 105. Zydus Pharmaceuticals Key News & Latest Developments
Table 106. Acella Pharmaceuticals Company Summary
Table 107. Acella Pharmaceuticals Topical Antifungals Product Offerings
Table 108. Acella Pharmaceuticals Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 109. Acella Pharmaceuticals Key News & Latest Developments
Table 110. Akorn Company Summary
Table 111. Akorn Topical Antifungals Product Offerings
Table 112. Akorn Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 113. Akorn Key News & Latest Developments
Table 114. Alembic Pharmaceuticals Company Summary
Table 115. Alembic Pharmaceuticals Topical Antifungals Product Offerings
Table 116. Alembic Pharmaceuticals Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 117. Alembic Pharmaceuticals Key News & Latest Developments
Table 118. Bausch & Lomb Americas Company Summary
Table 119. Bausch & Lomb Americas Topical Antifungals Product Offerings
Table 120. Bausch & Lomb Americas Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 121. Bausch & Lomb Americas Key News & Latest Developments
Table 122. Encube Company Summary
Table 123. Encube Topical Antifungals Product Offerings
Table 124. Encube Topical Antifungals Revenue (US$, Mn) & (2018-2023)
Table 125. Encube Key News & Latest Developments
List of Figures
Figure 1. Topical Antifungals Segment by Type in 2022
Figure 2. Topical Antifungals Segment by Application in 2022
Figure 3. Global Topical Antifungals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Topical Antifungals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Topical Antifungals Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Topical Antifungals Revenue in 2022
Figure 8. By Type - Global Topical Antifungals Revenue Market Share, 2018-2029
Figure 9. By Application - Global Topical Antifungals Revenue Market Share, 2018-2029
Figure 10. By Type - Global Topical Antifungals Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Topical Antifungals Revenue Market Share, 2018-2029
Figure 12. By Application - Global Topical Antifungals Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Topical Antifungals Revenue Market Share, 2018-2029
Figure 14. By Region - Global Topical Antifungals Revenue Market Share, 2018-2029
Figure 15. By Country - North America Topical Antifungals Revenue Market Share, 2018-2029
Figure 16. US Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Topical Antifungals Revenue Market Share, 2018-2029
Figure 20. Germany Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 21. France Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Topical Antifungals Revenue Market Share, 2018-2029
Figure 28. China Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 32. India Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Topical Antifungals Revenue Market Share, 2018-2029
Figure 34. Brazil Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Topical Antifungals Revenue Market Share, 2018-2029
Figure 37. Turkey Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Topical Antifungals Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Coloplast Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sandoz Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. 3M Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Schering-Plough Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Zydus Lifesciences Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Pharmaceuticals Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Perrigo Pharmaceuticals Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Roxane Laboratories Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AdvaCare Pharma Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Smith & Nephew Wound Care Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Taro Pharmaceutical Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Teligent Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. G & W Labs Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Glenmark Pharmaceuticals Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Mayne Pharma Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. TruPharma Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Viona Pharmaceuticals Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Zydus Pharmaceuticals Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Acella Pharmaceuticals Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Akorn Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Alembic Pharmaceuticals Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Bausch & Lomb Americas Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Encube Topical Antifungals Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

※参考情報

局所投与用抗真菌薬は、真菌感染症に対する治療に特化した薬剤であり、主に皮膚や粘膜の表面に直接適用される形態で提供されます。この種の薬剤は、真菌の成長を抑制したり、死滅させたりすることで、感染症を治療することを目的としています。局所投与用抗真菌薬は、全身投与に比べて副作用が少なく、患部に高濃度で薬剤を届けることができるため、特に皮膚真菌症や爪真菌症など局所的な感染症の治療に多く利用されます。

局所投与用抗真菌薬の特徴としては、まずその投与方法があります。一般的にはクリーム、ローション、液体、スプレー、パウダーなどの形態で提供され、対象となる部位に直接塗布することができます。このため、皮膚や粘膜の病変部分に高濃度で薬剤を届けることが可能です。また、全身的な副作用が少なく、肝機能や腎機能に対する負担が軽減されることも大きな利点です。

局所投与用抗真菌薬には多くの種類があります。その中には、アゾール系、ポリエン系、スピロニノール系、アリルアミン系などが含まれます。アゾール系は、真菌細胞膜の成分であるエルゴステロールの合成を阻害することにより、真菌の成長を抑制します。代表的な薬剤としては、クロトリマゾールやミコナゾールなどがあります。ポリエン系の抗真菌薬は、真菌細胞膜に直接作用し、膜を破壊することによって真菌を死滅させます。ナタマイシンがこのカテゴリーに属します。

スピロニノール系の薬剤は、真菌の細胞壁に作用し、その合成を阻害するタイプの薬剤です。アリルアミン系の代表的な薬剤には、テルビナフィンがあります。この薬剤は、特に皮膚や爪の真菌感染症に対して高い効果を示します。

局所投与用抗真菌薬の用途は多岐にわたります。最も一般的な使用例は、皮膚真菌症です。これは、特に水虫やティニア・ペディス、頭皮の真菌感染など、皮膚や爪に影響を及ぼす病気を含みます。これらの疾患は、主に皮膚の表面に生息する真菌によって引き起こされ、局所投与用抗真菌薬は非常に効果的です。

一方で、真菌の種類によっては、治療に時間を要する場合や、薬剤耐性が問題になることもあります。特に爪真菌症は治療が困難であり、効果的な局所剤を数か月間、継続的に使用する必要があります。また、真菌の感染による症状は皮膚の痒みや炎症を伴うため、治療が遅れるとさらに悪化するリスクがあります。

最近の技術の進展により、局所投与用抗真菌薬はさらに進化しています。新しい製剤技術としては、ナノテクノロジーを活用した薬剤送達システムが注目されています。ナノ粒子を用いることで、薬剤の浸透性が向上し、局所投与でありながら全身的な効果を期待できるようになります。また、経皮吸収促進剤やリポソームなどの技術も、真菌感染症のより効果的な治療につながる可能性があります。

さらには、分子生物学的手法を用いた抗真菌薬の開発も進んでいます。これにより、特定の真菌に対する選択的な治療が可能となり、既存の薬剤に対する耐性を持つ菌株に対抗する新たな治療戦略が提供されることが期待されています。こうした技術革新により、今後ますます多様な局所投与用抗真菌薬が登場するでしょう。

このように、局所投与用抗真菌薬は、真菌感染症の治療において多くの利点を持った重要な治療手段です。副作用が少なく、効果的に感染部位に作用することで、患者の生活の質を向上させる役割を果たしています。新たな技術の進展によって、今後もその効果と安全性が一層向上することが期待され、真菌感染症に対する戦略はますます強化されていくことでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 局所投与用抗真菌薬の世界市場見通し2023年-2029年(Topical Antifungals Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

局所投与用抗真菌薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp